Long-lived B cell Immunity in the Respiratory Tract

呼吸道中的长寿命 B 细胞免疫

• 批准号: 8134252
• 负责人: Nicole Baumgarth
• 金额: $ 37.54万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-01 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8134252
• 关键词: Adoptive Transfer; Antibodies; Antibody Formation; Antigens; Appearance; Attenuated; B-Lymphocytes; Blood Vessels; Cells; Characteristics; Custom; Data; Development; Devices; Gene Expression; Generations; Genetic Screening; Goals; Humoral Immunities; Immune; Immune response; Immunity; Immunization; Immunoglobulin-Secreting Cells; Inactivated Vaccines; Infection; Inflammation; Inflammatory; Influenza; Influenza Hemagglutinin; Integrins; Kinetics; Knowledge; Label; Licensing; Life; Longevity; Lung; Lung Capacity; Lung Inflammation; Maintenance; Measures; Microfluidic Microchips; Modeling; Mucosal Immune Responses; Mucosal Immunity; Mus; Pathway interactions; Plasma Cells; Plasmablast; Regulation; Reporter; Respiratory System; Respiratory Tract Infections; Respiratory physiology; Respiratory tract structure; Signal Transduction; Site; Source; Staging; Structure of germinal center of lymph node; Structure of parenchyma of lung; System; Vaccination; Vaccine Design; Vaccines; Virus; Virus Diseases; arm; base; chemokine; chemokine receptor; influenzavirus; lymph nodes; migration; mimetics; novel; pathogen; public health relevance; research study; response; shear stress; success

DESCRIPTION (provided by applicant): Respiratory tract infections induce strong and long-lasting humoral immune responses locally at the site, contributing significantly to immune protection from challenge infection. The mechanisms that induce and control protective local immune responses are currently not fully understood. The study is based on preliminary data in mice that implicate the rapidly induced extrafollicular foci B cell response as source for long-lived humoral immunity in the respiratory tract following influenza virus infection. The objective for this proposal is to identify the mechanisms that regulate this long-term local antibody response to influenza virus in the respiratory tract. In Specific Aim #1 the differentiation pathways and protective capacity of lung antibody-secreting cells following influenza virus infection will be measured in wildtype mice and in mice that lack formation of germinal centers (SAP-/- mice) or strong extrafollicular foci responses (following inactivated virus delivery) using BLIMP-1 reporter mice and a newly developed system for tracking of influenza hemagglutinin-specific, C12Id-expressing B cells ex vivo. Specific Aim #2 will study the mechanisms regulating the migration/retention of lung plasma cell precursors to the respiratory tract. They will assess the extent to which migration of virus-specific B cells/plasma cells from regional lymph nodes is required for the establishment of lung tissue plasma cell pools, and using genetic screening and a custom microfluidics device, will identify the integrins and chemokines/receptors responsible for the selective accumulation and/or retention of plasma cells the lung tissue under shear stress. Specific Aim #3 will use gene expression studies to determine the differentiation stage of plasma cells/precursors in the lung tissue and BrDU labeling studies to identify the mechanisms underlying the longevity of the antibody-secreting cells in the lung. Adoptive transfer studies will assess the requirements for antigen and/or infection-induced inflammatory signals for their maintenance. These studies will provide novel information on the characteristics and the B cell developmental pathways that generate the long-lived humoral immune responses in the respiratory tract, basic knowledge on B cell response regulation that can aid rationale vaccine design. PUBLIC HEALTH RELEVANCE: Protection from infections with influenza virus is contributed at least in part by antibody-secreting cells that establish in the lung following influenza virus infection. This study aims to understand how these cells are generated and what regulates their migration/maintenance in the lung. This basic information will provide potential avenues for rational vaccine design that aims to boost local/mucosal immune responses.

描述(由申请人提供)：呼吸道感染在现场局部诱导强烈和持久的体液免疫反应，显著促进对挑战感染的免疫保护。诱导和控制保护性局部免疫反应的机制目前还不完全清楚。这项研究是基于小鼠的初步数据，这些数据表明，在流感病毒感染后，快速诱导的滤泡外病灶B细胞反应是呼吸道长期体液免疫的来源。这项建议的目的是确定调节呼吸道对流感病毒的这种长期局部抗体反应的机制。在特定目标#1中，将使用BLIMP-1报告小鼠和新开发的用于体外跟踪流感血凝素特异性、表达C12ID的B细胞的系统，在野生型小鼠和缺乏生发中心(SAP-/-小鼠)或强毛囊外病灶反应(灭活病毒传递后)的小鼠中测量流感病毒感染后肺抗体分泌细胞的分化途径和保护能力。具体目标#2将研究肺浆细胞前体向呼吸道迁移/保留的调节机制。他们将评估建立肺组织浆细胞库需要从区域淋巴结迁移病毒特异性B细胞/浆细胞的程度，并使用基因筛查和定制的微流体设备，将确定在剪切力下导致血浆细胞选择性聚集和/或滞留肺组织的整合素和趋化因子/受体。具体目标#3将使用基因表达研究来确定肺组织中浆细胞/前体细胞的分化阶段，并使用BrDU标记研究来确定肺中抗体分泌细胞长寿的机制。过继转移研究将评估维持其对抗原和/或感染诱导的炎症信号的需求。这些研究将提供有关在呼吸道产生长寿体液免疫反应的特性和B细胞发育途径的新信息，以及有助于疫苗设计的B细胞反应调节的基本知识。 公共卫生相关性：对感染流感病毒的保护至少部分是由流感病毒感染后在肺部建立的抗体分泌细胞起作用的。这项研究旨在了解这些细胞是如何产生的，以及是什么调节它们在肺中的迁移/维持。这些基本信息将为旨在增强局部/粘膜免疫反应的合理疫苗设计提供潜在途径。